Sequence and phylogenetic analysis of SH, G, and F genes and proteins of human respiratory syncytial virus isolates from Singapore

Acta Virologica

Volumn 47, Issue 2, 2003, Pages 97-104

  Lim, C S ^a   Kumarasinghe, G ^b   Chow, V T K ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

F, G, SH genes proteins; Genotypes; Human respiratory syncytial virus; Phylogeny; Sequence analysis

Indexed keywords

F PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN; SH PROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ADULT; AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; CHILD; EPIDEMIOLOGICAL DATA; F GENE; G GENE; GENETIC VARIABILITY; GENOTYPE; GLYCOSYLATION; HUMAN; MEMBRANE ASSOCIATED GENE; MOLECULAR PHYLOGENY; N GLYCOSYLATION; NUCLEOTIDE SEQUENCE; O GLYCOSYLATION; PHYLOGENETIC TREE; PHYLOGENY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEQUENCE ANALYSIS; SH GENE; SINGAPORE; VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN;

ADULT; AMINO ACID SEQUENCE; CHILD; DNA, VIRAL; EPIDEMIOLOGY, MOLECULAR; GENES, VIRAL; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; SINGAPORE; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS; PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS; SUBGROUP A; SUBGROUP B;

EID: 0042362121     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Anderson LJ, Hierholzer JC, Tsou C, Hendry RM, Fernie BF, Stone Y, McIntosh K (1985): Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J. Infect. Dis. 151, 626-633.
2. Bukreyev A, Whitehead SS, Murphy BR, Collins PL (1997): Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibit site-specific attenuation in the respiratory tract of the mouse. J. Virol. 71, 8973-8982.
3. Cane PA, Pringle CR (1991): Respiratory syncytial virus heterogeneity during an epidemic: analysis by limited nucleotide sequencing (SH gene) and restriction mapping (N gene). J. Gen. Virol. 72, 349-357.
4. Cane PA, Pringle CR (1992): Molecular epidemiology of human respiratory syncytial virus: rapid identification of subgroup A lineages. J. Virol. Methods 40, 297-306.
5. Cane PA, Matthews DA, Pringle CR (1991): Identification of variable domains of attachment (G) protein of subgroup A respiratory syncytial viruses. J. Gen. Virol 72, 2091-2096.
6. Chew FT, Doraisingham S, Ling AE, Kumarasinghe G, Lee BW (1998): Seasonal trends of viral respiratory tract infections in the tropics. Epidemiol. Infect. 121, 121-128.
7. Choi EH, Lee HJ (2000): Genetic diversity and molecular epidemiology of the G protein of subgroups A and B of respiratory syncytial viruses isolated over 9 consecutive epidemics in Korea. J. Infect. Dis. 181, 1547-1556.
8. Chow VTK, Leong PWF (1999): Complete nucleotide sequence, genomic organization and phylogenetic analysis of a novel genital human papillomavirus type, HLT7474-S. J. Gen. Virol. 80, 2923-2929.
9. Chungue E, Roche C, Lefevre M, Barbazan P, Chanteau S (1993): Ultra-rapid, simple, sensitive, and economical silica method for extraction of dengue viral RNA from clinical specimens and mosquitoes by reverse transcriptase-polymerase chain reaction. J. Med. Virol. 40, 142-145.
10. Garcia O, Martin M, Dopazo J, Arbiza J, Frabasile S, Russi J, Hortal M, Perez-Brena P, Martinez I, Garcia-Barreno B, Melero JA (1994): Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein. J. Virol. 68, 5448-5459.
11. Hall CB, Walsh EE, Long CE, Schnabel KC (1991): Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 163, 693-698.
12. Johnson PR, Spriggs MK, Olmsted RA, Collins PL (1987): The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc. Natl. Acad. Sci. USA 84, 5625-5629.
13. Lambert DM (1988): Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins. Virology 164, 458-466.
14. Mader D, Huang Y, Wang C, Fraser R, Issekutz AC, Stadnyk AW, Anderson R (2000): Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associated with virus challenge. Vaccine 18, 1110-1117.
15. Martinello RA, Chen MD, Weibel C, Kahn JS (2002): Correlation between respiratory syncytial virus genotype and seventy of illness. J. Infect. Dis. 186, 839-842.
16. Mufson MA, Orvell C, Rafnar B, Norrby E (1985): Two distinct subtypes of human respiratory syncytial virus. J. Gen. Virol. 166, 2111-2124.
17. Olmsted RA, Elango N, Prince GA, Murphy BR, Johnson PR. Moss B, Chanock RM, Collins PL (1986): Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc. Natl. Acad. Sci. USA 83, 7462-7466.
18. Palomo C, Garcia-Barreno B, Penas C, Melero JA (1991): The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity. J. Gen. Virol. 72, 669-675.
19. Peret TCT, Hall CB, Schnabel KC, Golub JA, Anderson LJ (1998): Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J. Gen. Virol. 79, 2221-2229.
20. Peret TCT, Hall CB, Hammond GW, Piedra PA, Storch GA. Sullender WM, Tsou C, Anderson LJ (2000): Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J. Infect. Dis. 181, 1891-1896.
21. Pollack P, Groothuis JR, Barbarotto GM (2002): Development and use of palivizumab (Synagis): a passive immunoprophylactic agent for RSV. J. Infect. Chemother 8, 201-206.
22. Roca A, Loscertales MP, Quinto L, Perez-Brena P, Vaz N, Alonso PL, Saiz JC (2001): Genetic variability among group A and B respiratory syncytial viruses in Mozambique: identification of a new cluster of group B isolates. J Gen. Virol. 82, 103-111.
23. Scopes GE, Watt PJ, Lambden PR (1990): Identification of a linear epitope on the fusion glycoprotein of respiratory syncytial virus. J. Gen. Virol. 71, 53-59.
24. Sullender WM, Mufson MA, Anderson LJ, Wertz GW (1991): Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses. J. Virol. 65, 5425-5434.
25. Taylor G, Stott EJ, Bew M, Fernie BF, Cote PJ. Collins AP, Hughes M, Jebbett J (1984): Monoconal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52, 137-142.
26. Venter M, Madhi SA, Tiemessen CT, Schoub BD (2001): Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes. J. Gen. Virol. 82, 2117-2124.
27. Venter M, Collinson M, Schoub BD (2002): Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: comparison of viruses and genotypes responsible for different disease manifestations. J. Med. Virol. 68, 452-461.
28. Walsh EE, McConnochie KM, Long CE, Hall CB (1997): Severity of respiratory syncytial virus infection is related to virus strain. J. Infect. Dis. 175, 814-820.
29. Zheng H, Storch GA, Zang C, Peret TCT, Park CS. Anderson LJ (1999): Genetic variability in envelope-associated protein genes of closely related groups A strains of respiratory syncytial virus. Virus Res. 59, 89-99.